• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Training and Continuing Education

  • Print
  • Share
  • E-mail

Section Contents Menu

  • CDERLearn


    Welcome to CDERLearn, the web page for educational tutorials offered by the Center for Drug Evaluation and Research. CDER's primary mission is to make certain that safe and effective drugs are available to the American people. There is, however, a strategic initiative to inform and educate people about the safe use of medicine, the drug regulatory process, the vital role health care professionals play to assist FDA in fulfilling its duties, and many other important issues. Online training is one way to share FDA expertise with many more people than face-to-face classroom sessions would allow, and we will offer additional CDER courses in the future.


    Course List

    • CDER World (Unavailable until 2013)
      An Evolving Series of Multimedia Modules Based on The CDER Forum for International Regulatory Authorities Lectures (Dedicated to Capt. Justina A. Molzon, MSPharm, JD, founder of the CDER Forum)
    • The Past, Present, and Future of FDA Human Drug Regulation
      An updated version of "Drug Review and Related Activities in the United States," with continuing education (CE) credit for pharmacists, physicians, and nurses. The program gives health care professionals, industry, consumers, and all other interested participants an overview of the human drug regulatory process in the United States. CE Credit available through June 28, 2013. Course time: approximately 90 minutes
    • Medicines in My Home -An Interactive Home   
      This educational program is designed to help consumers from adolescence to adulthood understand and use the Drug Facts label to choose over-the-counter medicines and use them safely.
    • Bringing an Unapproved Drug Into Compliance (Unavailable until 2013)  
      The primary audience for this course is manufacturers/distributors of drugs marketed without FDA approval or compliance with an OTC monograph. The secondary audience is health care providers and organizations that establish formularies. Course Time: Approximately 90 minutes
    • Risk Assessment and Communication  
      This CME program offered through Discover Health explains ways that physicians can communicate risk to their patients to help them make informed health care decisions. Available for credit through June 27, 2011

    • FDA Medwatch and Patient Safety  
      An online tutorial covering the MedWatch program goals of broadcasting safety information and encouraging adverse event reporting
    • Field Investigators: Adverse Drug Effects (ADE) Investigators (2000)  
    • The FDA Process for Approving Generic Drugs  
      Credit is no longer available for this course.

    • An Introduction to the Improved FDA Prescription Drug Labeling  
      Credit is no longer available for this course. The primary audience for this course content is physicians, physician assistants, pharmacists, nurses, nurse practitioners, and dentists. Secondary audiences include other health practitioners who are interested in the revised prescription drug labeling.



    Contact FDA

    Toll Free
    (855) 543-3784, or
    (301) 796-3400
    Human Drug Information

    Division of Drug Information (CDER)

    Office of Communications

    Feedback Form

    10001 New Hampshire Avenue

    Hillandale Building, 4th Floor

    Silver Spring, MD 20993